Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design.
| Image |  |
|---|---|
| Description | scientific article published on 19 August 2011 |
| Author/s |
author: Mark G Kris Jamie E Chaft Camelia S Sima |
| Publication date | August 19, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |